Prognostic factors and outcome of Epstein–Barr virus DNAemia in high‐risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab
暂无分享,去创建一个
R. Fanin | M. Isola | F. Barbone | F. Patriarca | G. Gregoraci | M. Medeot | C. Savignano | C. Rinaldi | E. Toffoletti | A. Geromin | A. Michelutti | A. Sperotto | M. Cerno | C. Pipan | M. Dozzo | M. Battista